VYNE Therapeutics Statistics

Total Valuation

VYNE has a market cap or net worth of $18.54 million. The enterprise value is -$31.67 million.

Market Cap	18.54M
Enterprise Value	-31.67M

Important Dates

The last earnings date was Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

VYNE has 14.83 million shares outstanding. The number of shares has increased by 111.95% in one year.

Current Share Class	14.83M
Shares Outstanding	14.83M
Shares Change (YoY)	+111.95%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	5.96%
Owned by Institutions (%)	34.71%
Float	10.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	88.05
Forward PS	60.58
PB Ratio	0.45
P/TBV Ratio	0.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.47, with a Debt / Equity ratio of 0.00.

Current Ratio	4.47
Quick Ratio	4.09
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -66.15% and return on invested capital (ROIC) is -44.48%.

Return on Equity (ROE)	-66.15%
Return on Assets (ROA)	-38.36%
Return on Invested Capital (ROIC)	-44.48%
Return on Capital Employed (ROCE)	-103.00%
Revenue Per Employee	$46,538
Profits Per Employee	-$3.25M
Employee Count	13
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, VYNE has paid $4,000 in taxes.

Income Tax	4,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.18% in the last 52 weeks. The beta is 1.77, so VYNE's price volatility has been higher than the market average.

Beta (5Y)	1.77
52-Week Price Change	-53.18%
50-Day Moving Average	1.70
200-Day Moving Average	2.23
Relative Strength Index (RSI)	32.97
Average Volume (20 Days)	232,984

Short Selling Information

The latest short interest is 217,471, so 1.47% of the outstanding shares have been sold short.

Short Interest	217,471
Short Previous Month	191,069
Short % of Shares Out	1.47%
Short % of Float	2.13%
Short Ratio (days to cover)	0.91

Income Statement

In the last 12 months, VYNE had revenue of $605,000 and -$42.20 million in losses. Loss per share was -$0.99.

Revenue	605,000
Gross Profit	605,000
Operating Income	-45.45M
Pretax Income	-29.08M
Net Income	-42.20M
EBITDA	n/a
EBIT	-45.45M
Loss Per Share	-$0.99

Full Income Statement

Balance Sheet

The company has $50.27 million in cash and $63,000 in debt, giving a net cash position of $50.21 million or $3.39 per share.

Cash & Cash Equivalents	50.27M
Total Debt	63,000
Net Cash	50.21M
Net Cash Per Share	$3.39
Equity (Book Value)	44.13M
Book Value Per Share	2.77
Working Capital	42.62M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-7,513.06%
Pretax Margin	-6,969.42%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VYNE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-111.95%
Shareholder Yield	-111.95%
Earnings Yield	-227.62%
FCF Yield	n/a

Analyst Forecast

The average price target for VYNE is $6.25, which is 400.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.25
Price Target Difference	400.00%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	129.39%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 13, 2023. It was a reverse split with a ratio of 0.0555556:1.

Last Split Date	Feb 13, 2023
Split Type	Reverse
Split Ratio	0.0555556:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1